External reports (aggregated public sources), Value Investors Club

Value Investors Club

External reports (aggregated public sources)

Equity Bottom-Up

<ul><li>ACRC is a biotech pharma micro-cap company trading below its net cash value</li><li>Downsized workforce after a failed phase 2 trial, CEO and CMO left prompting strategic evaluation</li><li>Activist investors involved, potential for monetization of stakes to benefit shareholders.</li></ul><p><em>This content is sourced through publicly available sources and has been machine generated. Information displayed is for general informational purposes only. This article was originally published 3 months ago on Value Investors Club.</em></p>

ACRC is a biotech pharma micro-cap company trading below its net cash valueDownsized workforce after a failed phase 2 trial, CEO and CMO left prompting strategic evaluationActivist investors involved, potential for monetization of stakes to benefit shareholders.This content is sourced through publicly available sources and has been machine generated. Information displayed is for general informational purposes only. This article was originally published 3 months ago on Value Investors Club.

Aclaris Therapeutics Inc (ACRS) - Sunday, Mar 24, 2024

United States

Zynerba Pharmaceuticals, Inc. is a specialty pharmaceutical company. The Company develops next-generation synthetic cannabinoid therapeutics for transdermal delivery for patients with significant unmet medical needs. Zynerba Pharmaceuticals serves the healthcare sector and patients in the United States.

Assembly Biosciences Inc. is a biopharmaceutical company. The Company is focused in the field of infectious diseases such as the Hepatitis B virus (HBV) and clostridium difficile (CDAD). Assembly is developing two proprietary platforms: an HBV-cure platform focused on oral drugs with novel direct-acting mechanisms, and an orally-delivered microbiome therapeutics platform for treating CDAD.

Paratek Pharmaceuticals, Inc. is a biopharmaceutical company that engages in the development and commercialization of antibiotics. The Company develops medicine for serious community-acquired bacterial infections. Paratek Pharmaceuticals' products treat patients in both the community and hospital setting.

Odonate Therapeutics, Inc. operates as a pharmaceutical company. The Company develops an oral chemotherapy drugs for the treatment of cancer. Odonate Therapeutics offers its services worldwide.

NGM Biopharmaceuticals, Inc. operates as a clinical-stage biopharmaceutical company. The Company focuses on developing novel therapeutics based on scientific understanding of key biological pathways underlying cardio-metabolic, liver, oncologic, and ophthalmic diseases. NGM Biopharmaceuticals serves medical industry in the United States.

Sienna Biopharmaceuticals, Inc. is a clinical-stage biopharmaceutical company. The Company develops, discovers, and commercializes aesthetics and dermatology based products for inflammatory skin diseases, tissue injury, and unwanted light-pigmented hair reduction. Sienna Biopharmaceuticals serves patients in the United States and Italy.

Optinose, Inc. offers health care services. The Hospital offers ear, nose, and throat surgery, as well as provides treating of nasal and sinus diseases, research, development, medication of migraine, clinical data analysis, diagnosis, and other services. Optinose operates worldwide.

scPharmaceuticals Inc. operates as a pharmaceutical company. The Company focuses on the development of subcutaneous furosemide and a cephalosporin antibiotic products for the treatment of worsening and heart failure of inpatient setting. scPharmaceuticals serves patients in the State of Massachusetts.

Kubota Pharmaceutical Holdings Co.,Ltd. operates as a holding company. The company, through its subsidiaries, specializes in identifying and developing therapeutics to treat the ophthalmic disorders. Kubota Pharmaceutical Holdings serves customers worldwide.

TherapeuticsMD, Inc. is a specialty pharmaceutical company focused on creating safe and effective branded and generic prescription, and over-the-counter products targeted exclusively for women. The Company develops three advanced hormone replacement products designed to alleviate the symptoms of and reduce the health risks resulting from menopause-related hormone deficiencies.

Samsung Pharmaceutical Co., Ltd. manufactures medicines to treat a variety of diseases.  The Company's products include medicines for inflammatory, nutrition, and digestive system.

Albert David Ltd. manufactures a variety of pharmaceutical products, vitamins, external application lotions, I.V. sets and disposable syringes and needles. The Company's leading products include "Plcentrex Lotion", "Adilox Capsules", "Sioplex Capsules", "Siotone" (a fitness capsule) and "Adliv Forte Capsule/Syrup" (for liver disorder).

Hwail Pharm Co., Ltd. produces pharmaceutical raw materials.  The Company's products include Talniflumate, Alibendol, and Oxatomide.  Hwail supplies these materials to companies dealing with finished pharmaceutical products.

Genovate Biotechnology Co., Ltd. produces and markets antimicrobial agents, antineoplastic agents, cardiovascular system drugs, digestive system drugs, external agents, nervous system drugs, non-addictive analgesics and anti-inflammatory drugs, urinary system drugs, and vitamins.

Jeil Pharma Holdings Inc. operates as a pharmaceutical manufacturing company. The Company manufactures analgesic anti-inflammatories, broad-spectrum oral antimicrobial agents, analgesic anti-cold poultice poultices, hyperlipidemia agents, intravenous antibiotics, and other products. Jeil Pharma Holdings markets its products throughout Korea.

Kukje Pharma Ind. Co., Ltd. manufactures medical drugs.  The Company's products include antibiotics, vitamins, nutritional agents, and other drugs for supply to hospitals.  Kukje Pharma Ind. also sells apartments.

Daehan New Pharm Co., Ltd. develops, manufactures, and markets pharmaceutical drugs, such as vaccines, diagnostic kits, and antibiotics.  The Company also produces various veterinary drugs and baby cares.  Daehan New Pharm exports its products to Japan, Malaysia, Vietnam, and Brazil.

Hangzhou Tian-Mu-Shan Pharmaceutical Enterprise Co., Ltd. researches, manufactures, and markets traditional Chinese medicines, western medicines, and biomedicines.  The Company also manufactures printed circuit boards and paper products.

Hangzhou Tian Mu Shan Pharm. Enterp. Co (600671 CH)

Y.S.P. Southeast Asia Holdings Bhd is an investment holding company. The Company, through its subsidiaries, imports, exports, manufactures and trades pharmaceutical and veterinary products.

Ind-Swift Laboratories Ltd. manufactures bulk drugs and intermediates.  The Company's product portfolio includes anti-infective, anti-allergy, analgesic and cardiovascular medicines.

Aclaris Therapeutics, Inc. operates as a clinical-stage specialty pharmaceutical company. The Company focuses on identifying, developing, and commercialization topical drugs to address significant unmet needs in dermatology. Aclaris Therapeutics offers a topical therapy for the treatment of seborrheic keratosis and other verrucoid lesions of the skin.

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Aclaris Therapeutics (ACRS US)

Aclaris Therapeutics Inc (ACRS) - Sunday, Mar 24, 2024

ACRC is a biotech pharma micro-cap company trading below its net cash value. Downsized workforce after a failed phase 2 trial, CEO and CMO left...

Value Investors Club

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)